These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23158779)

  • 1. Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.
    Wojtalik JA; Eack SM; Pollock BG; Keshavan MS
    Psychiatry Res; 2012 Nov; 204(2-3):61-7. PubMed ID: 23158779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
    Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
    Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
    Eack SM; Hogarty GE; Cho RY; Prasad KM; Greenwald DP; Hogarty SS; Keshavan MS
    Arch Gen Psychiatry; 2010 Jul; 67(7):674-82. PubMed ID: 20439824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia.
    Schreiber SR; Wojtalik JA; Walker CP; Cho RY; Eack SM; Keshavan MS
    Psychiatry Res Neuroimaging; 2018 Nov; 281():31-34. PubMed ID: 30216862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.
    Vinogradov S; Fisher M; Warm H; Holland C; Kirshner MA; Pollock BG
    Am J Psychiatry; 2009 Sep; 166(9):1055-62. PubMed ID: 19570929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.
    Keshavan MS; Eack SM; Wojtalik JA; Prasad KM; Francis AN; Bhojraj TS; Greenwald DP; Hogarty SS
    Schizophr Res; 2011 Aug; 130(1-3):123-9. PubMed ID: 21645997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volume and dysexecutive behavior in schizophrenia.
    Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ; Poole JH; Benton C; Vinogradov S
    Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia.
    Rüsch N; Spoletini I; Wilke M; Bria P; Di Paola M; Di Iulio F; Martinotti G; Caltagirone C; Spalletta G
    Schizophr Res; 2007 Jul; 93(1-3):79-89. PubMed ID: 17383859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced neuro-integration from the dorsolateral prefrontal cortex to the whole brain and executive dysfunction in schizophrenia patients and their relatives.
    Su TW; Lan TH; Hsu TW; Biswal BB; Tsai PJ; Lin WC; Lin CP
    Schizophr Res; 2013 Aug; 148(1-3):50-8. PubMed ID: 23726722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray matter volume deficits are associated with motor and attentional impairments in adolescents with schizophrenia.
    Kumra S; Ashtari M; Wu J; Hongwanishkul D; White T; Cervellione K; Cottone J; Szeszko PR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):939-43. PubMed ID: 21216271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial frontal gyrus alterations in schizophrenia: relationship with duration of illness and executive dysfunction.
    Frascarelli M; Tognin S; Mirigliani A; Parente F; Buzzanca A; Torti MC; Tinelli E; Caramia F; Di Fabio F; Biondi M; Fusar-Poli P
    Psychiatry Res; 2015 Feb; 231(2):103-10. PubMed ID: 25498920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between prefrontal gray matter volumes and working memory performance in schizophrenia: a family study.
    Goghari VM; Macdonald AW; Sponheim SR
    Schizophr Res; 2014 Mar; 153(1-3):113-21. PubMed ID: 24529364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia.
    Kumari V; Peters ER; Fannon D; Antonova E; Premkumar P; Anilkumar AP; Williams SC; Kuipers E
    Biol Psychiatry; 2009 Sep; 66(6):594-602. PubMed ID: 19560121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between aerobic fitness and executive function is mediated by prefrontal cortex volume.
    Weinstein AM; Voss MW; Prakash RS; Chaddock L; Szabo A; White SM; Wojcicki TR; Mailey E; McAuley E; Kramer AF; Erickson KI
    Brain Behav Immun; 2012 Jul; 26(5):811-9. PubMed ID: 22172477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.
    Wojtalik JA; Eack SM; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():207-12. PubMed ID: 23041620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural neuroanatomy of metacognitive insight in schizophrenia and its psychopathological and neuropsychological correlates.
    Spalletta G; Piras F; Piras F; Caltagirone C; Orfei MD
    Hum Brain Mapp; 2014 Sep; 35(9):4729-40. PubMed ID: 24700789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.